AI Summary

The FDA approved Zanvastro, the first disease‑modifying drug for Alexander disease, a rare neurological disorder that can impair motor, cognitive, and autonomic functions such as heart rate and breathing. The approval marks the first treatment option for a condition that has been largely untreatable for decades. Zanvastro is the only drug currently available that targets the underlying disease process of Alexander disease.

AI summaries can be wrong sometimes—always verify important details using the source article.